Domestic firms’ strategic alliances with multinational firms up

A number of domestic pharmaceutical companies have already established strategic alliances with multinational drug manufacturers for co-marketing and/or co-development of new drugs to effectively minimize outlays for sales and development of new drugs.

Regardless of company size, this trend of such strategic alliance is expected to accelerate riding high in a bid to soften the impacts caused...